Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Diabetologia. 2021 Aug;64(8):1775-1784. doi: 10.1007/s00125-021-05459-7. Epub 2021 Apr 28.
AIMS/HYPOTHESIS: Our aim was to compare the contributions of impaired beta cell function (IBF) and insulin resistance with the development of type 2 diabetes in a Japanese community.
A total of 2094 residents aged 40-79 years without diabetes underwent a health examination including a 75 g OGTT in 2007. Participants were divided into four groups according to the presence or absence of IBF (insulinogenic index/HOMA-IR ≤28.5) and insulin resistance (HOMA-IR ≥1.61) and were followed up for 7 years (2007-2014). Cox's proportional hazards model was used to estimate HRs and 95% CIs for type 2 diabetes. The population attributable fractions (PAFs) due to IBF, insulin resistance, and their combination were calculated.
At baseline, the prevalence of isolated IBF, isolated insulin resistance, and both IBF and insulin resistance were 5.4%, 24.1% and 9.5%, respectively. During the follow-up period, 272 participants developed type 2 diabetes. The multivariable-adjusted HRs (95% CI) and PAFs (95% CI) for type 2 diabetes were 6.3 (4.3, 9.2) and 13.3% (8.7, 17.7) in the participants with isolated IBF, 1.9 (1.3, 2.7) and 10.5% (4.0, 16.6) in those with isolated insulin resistance, and 8.0 (5.7, 11.4) and 29.3% (23.0, 35.1) in those with both IBF and insulin resistance, respectively, compared with the participants without either.
CONCLUSIONS/INTERPRETATION: The present study suggests that the combination of IBF and insulin resistance makes the main contribution to the development of type 2 diabetes in Japanese communities.
目的/假设:我们的目的是比较日本社区中β细胞功能受损(IBF)和胰岛素抵抗对 2 型糖尿病发展的贡献。
共有 2094 名年龄在 40-79 岁之间、无糖尿病的居民参加了 2007 年的健康检查,包括 75g OGTT。根据是否存在 IBF(胰岛素原指数/HOMA-IR≤28.5)和胰岛素抵抗(HOMA-IR≥1.61),将参与者分为四组,并随访 7 年(2007-2014 年)。采用 Cox 比例风险模型估计 2 型糖尿病的 HR 和 95%CI。计算 IBF、胰岛素抵抗及其组合导致的人群归因分数(PAF)。
在基线时,孤立性 IBF、孤立性胰岛素抵抗和 IBF 与胰岛素抵抗并存的患病率分别为 5.4%、24.1%和 9.5%。在随访期间,有 272 名参与者发生 2 型糖尿病。多变量调整后的 HR(95%CI)和 PAF(95%CI)分别为 IBF 组 6.3(4.3,9.2)和 13.3%(8.7,17.7)、胰岛素抵抗组 1.9(1.3,2.7)和 10.5%(4.0,16.6)、IBF 和胰岛素抵抗并存组 8.0(5.7,11.4)和 29.3%(23.0,35.1),与无 IBF 或胰岛素抵抗的参与者相比。
结论/解释:本研究表明,IBF 和胰岛素抵抗的结合是日本社区 2 型糖尿病发展的主要原因。